Scimago Journal & Country Rank
menu
| Title | Type |  SJR |
H index | Total Docs. (2013) | Total Docs. (3years) | Total Refs. (2013) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2013) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Nature Reviews Drug Discovery | journal | 7.283 Q1 | 391 | 211 | 686 | 7324 | 7492 | 405 | 9.97 | 34.71 |  |
| 2 | Trends in Pharmacological Sciences | journal | 5.425 Q1 | 244 | 92 | 256 | 5973 | 2800 | 240 | 10.36 | 64.92 | |
| 3 | Neuropsychopharmacology | journal | 5.270 Q1 | 249 | 275 | 785 | 15903 | 6635 | 722 | 7.24 | 57.83 | |
| 4 | Natural Product Reports | journal | 3.094 Q1 | 211 | 64 | 237 | 11257 | 2411 | 231 | 10.36 | 175.89 | |
| 5 | Particle and Fibre Toxicology | journal | 2.857 Q1 | 119 | 64 | 124 | 3015 | 1238 | 119 | 7.57 | 47.11 | |
| 6 | Journal of Antimicrobial Chemotherapy | journal | 2.479 Q1 | 221 | 505 | 1510 | 13833 | 7718 | 1209 | 5.01 | 27.39 | |
| 7 | Neuropharmacology | journal | 2.428 Q1 | 191 | 435 | 956 | 31006 | 4802 | 939 | 5.11 | 71.28 | |
| 8 | Clinical Pharmacokinetics | journal | 2.140 Q1 | 184 | 78 | 175 | 5515 | 1295 | 165 | 6.14 | 70.71 | |
| 9 | International Journal of Neuropsychopharmacology | journal | 2.121 Q1 | 125 | 202 | 368 | 11376 | 1818 | 354 | 4.52 | 56.32 | |
| 10 | Nanotoxicology | journal | 2.046 Q1 | 107 | 59 | 190 | 2921 | 1259 | 186 | 6.25 | 49.51 | |
| 11 | Expert Opinion on Therapeutic Targets | journal | 2.023 Q1 | 106 | 130 | 359 | 11733 | 1726 | 355 | 4.86 | 90.25 | |
| 12 | Drug Discovery Today | journal | 2.020 Q1 | 215 | 159 | 449 | 9878 | 3042 | 408 | 6.23 | 62.13 | |
| 13 | Environmental Pollution | journal | 1.976 Q1 | 301 | 494 | 1390 | 23832 | 6576 | 1360 | 4.39 | 48.24 | |
| 14 | Critical Reviews in Toxicology | journal | 1.948 Q1 | 129 | 47 | 121 | 5822 | 868 | 113 | 6.59 | 123.87 | |
| 15 | Toxicological Sciences | journal | 1.738 Q1 | 207 | 262 | 846 | 13014 | 4212 | 807 | 4.92 | 49.67 | |
| 16 | PharmacoEconomics | journal | 1.713 Q1 | 118 | 98 | 282 | 4577 | 995 | 240 | 3.47 | 46.70 | |
| 17 | Clinical Trials | journal | 1.683 Q1 | 74 | 110 | 247 | 2590 | 497 | 207 | 1.50 | 23.55 | |
| 18 | Protein and Cell | journal | 1.654 Q1 | 94 | 107 | 364 | 5145 | 1064 | 342 | 2.63 | 48.08 | |
| 19 | F1000 Biology Reports | journal | 1.635 Q1 | 32 | 2 | 138 | 163 | 391 | 137 | 4.68 | 81.50 | |
| 20 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 1.615 Q1 | 99 | 14 | 74 | 2197 | 389 | 68 | 5.04 | 156.93 | |
| 21 | CNS Neuroscience and Therapeutics | journal | 1.603 Q1 | 91 | 151 | 299 | 5770 | 1229 | 244 | 3.69 | 38.21 | |
| 22 | Journal of Psychopharmacology | journal | 1.592 Q1 | 135 | 129 | 573 | 8018 | 2123 | 541 | 3.71 | 62.16 | |
| 23 | Antiviral Therapy | journal | 1.554 Q1 | 93 | 135 | 485 | 4647 | 1590 | 466 | 3.22 | 34.42 | |
| 24 | Addictive Behaviors | journal | 1.516 Q1 | 149 | 238 | 666 | 10217 | 2147 | 664 | 2.84 | 42.93 | |
| 25 | Pharmacogenomics Journal | journal | 1.503 Q1 | 95 | 75 | 163 | 3320 | 901 | 162 | 5.46 | 44.27 | |
| 26 | Expert Opinion on Investigational Drugs | journal | 1.489 Q1 | 117 | 139 | 452 | 10890 | 1969 | 440 | 4.39 | 78.35 | |
| 27 | Expert Opinion on Drug Delivery | journal | 1.482 Q1 | 133 | 128 | 326 | 11044 | 1722 | 324 | 4.57 | 86.28 | |
| 28 | BMC Chemical Biology | journal | 1.418 Q1 | 21 | 0 | 14 | 0 | 45 | 14 | 1.14 | 0.00 | |
| 29 | Drug Safety | journal | 1.382 Q1 | 140 | 114 | 310 | 5160 | 1065 | 251 | 2.74 | 45.26 | |
| 30 | Expert Review of Vaccines | journal | 1.381 Q1 | 105 | 142 | 459 | 10084 | 1679 | 380 | 3.54 | 71.01 | |
| 31 | Clinical and Translational Science | journal | 1.353 Q1 | 60 | 82 | 251 | 1714 | 517 | 178 | 2.11 | 20.90 | |
| 32 | Journal of Cardiovascular Pharmacology and Therapeutics | journal | 1.299 Q1 | 57 | 68 | 155 | 2448 | 479 | 150 | 3.48 | 36.00 | |
| 33 | Expert Opinion on Biological Therapy | journal | 1.288 Q1 | 102 | 163 | 471 | 12106 | 1906 | 462 | 3.98 | 74.27 | |
| 34 | Journal of Exposure Science and Environmental Epidemiology | journal | 1.282 Q1 | 106 | 87 | 217 | 3380 | 625 | 206 | 3.15 | 38.85 | |
| 35 | British Journal of Clinical Pharmacology | journal | 1.272 Q1 | 167 | 276 | 684 | 11724 | 2319 | 534 | 3.22 | 42.48 | |
| 36 | Human Genomics | journal | 1.266 Q1 | 68 | 24 | 98 | 1098 | 310 | 88 | 3.05 | 45.75 | |
| 37 | Current Opinion in Investigational Drugs | journal | 1.265 Q1 | 83 | 0 | 144 | 0 | 544 | 143 | 0.00 | 0.00 | |
| 38 | Current Opinion in Molecular Therapeutics | journal | 1.212 Q1 | 67 | 0 | 88 | 0 | 342 | 87 | 0.00 | 0.00 | |
| 39 | Current Opinion in Drug Discovery and Development | journal | 1.199 Q1 | 85 | 0 | 68 | 0 | 277 | 67 | 0.00 | 0.00 | |
| 40 | Mutagenesis | journal | 1.195 Q1 | 102 | 84 | 268 | 3765 | 1020 | 259 | 3.79 | 44.82 | |
| 41 | Expert Opinion on Therapeutic Patents | journal | 1.188 Q1 | 88 | 112 | 330 | 9802 | 1165 | 324 | 3.50 | 87.52 | |
| 42 | Future Medicinal Chemistry | journal | 1.182 Q1 | 90 | 206 | 497 | 11429 | 1484 | 402 | 2.97 | 55.48 | |
| 43 | Clinical Toxicology | journal | 1.163 Q1 | 108 | 167 | 456 | 2992 | 1229 | 368 | 2.80 | 17.92 | |
| 44 | Expert Opinion on Drug Discovery | journal | 1.160 Q1 | 84 | 103 | 272 | 10456 | 986 | 272 | 3.68 | 101.51 | |
| 45 | Journal of Nanobiotechnology | journal | 1.154 Q1 | 109 | 51 | 136 | 1693 | 717 | 136 | 4.98 | 33.20 | |
| 46 | ChemMedChem | journal | 1.147 Q1 | 119 | 238 | 661 | 9017 | 2085 | 638 | 3.14 | 37.89 | |
| 47 | Therapeutic Advances in Neurological Disorders | journal | 1.144 Q1 | 68 | 31 | 88 | 2319 | 397 | 86 | 4.82 | 74.81 | |
| 48 | BMC Pharmacology | journal | 1.120 Q1 | 48 | 0 | 38 | 0 | 140 | 38 | 2.82 | 0.00 | |
| 49 | Tetrahedron | journal | 1.106 Q1 | 236 | 1323 | 3638 | 67114 | 10883 | 3617 | 3.02 | 50.73 | |
| 50 | Cardiovascular Therapeutics | journal | 1.089 Q1 | 54 | 72 | 190 | 3141 | 609 | 178 | 2.95 | 43.63 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data